Table 4.
Morbidity and mortality in ICU patients after contrast administration
| CA-AKI | CA-NAKI | OR | 95% CI | P | |
|---|---|---|---|---|---|
| (n = 52) | (n = 283) | ||||
| RRT after CM use | 18(34.6%) | 69(24.4%) | 1.6 | 0.87-3.09 | 0.13 |
| Diuretics after CM use | 37(71.2%) | 168(59.4%) | 0.12 | ||
| CM use after admission (days) | 4[0–51] | 4[0–80] | 0.68 | ||
| ICU discharge after CM use (days) | 6.5[1–124] | 7[1–285] | 0.83 | ||
| ICU LOS (days) | 14[1.5-26.5] | 15[6.5-23.5] | 0.98 | ||
| Hospital discharge after CM use (days) | 29[1–262] | 27[1–651] | 0.69 | ||
| ICU mortality | 21(40.4%) | 60(21.3%) | 2.5 | 1.34-4.67 | 0.01 |
| Hospital Mortality | 28(53.8%) | 101(35.7%) | 2.1 | 1.16-3.82 | 0.02 |
| Total mortality | 29(55.8%) | 108(38.2%) | 2.0 | 1.12-3.71 | 0.02 |
Data are presented as N (%), median [minimum-maximum].
OR odds ratio, CI confidence interval, P probability value.
CA-AKI contrast-associated acute kidney injury, CA-NAKI contrast-associated no acute kidney injury, RRT renal replacement therapy, CM contrast medium, ICU intensive care unit, LOS length of stay.